You are here
This trial is looking at volrustomig (MEDI5752) for head and neck cancer that has spread into the surrounding tissue and cannot be removed by surgery.
This study is looking at a drug called INCB106385 by itself or with another immunotherapy called retifanlimab (INCMGA00012) for some advanced solid cancers.
This trial is looking at adding certain targeted drugs to radiotherapy for head and neck cancer.
This trial is looking at adding monalizumab to cetuximab for people who have squamous cell cancer of the head and neck.
This trial is comparing lenvatinib and pembrolizumab with standard treatment for cancer of the head and neck.
This study is adjusting the plan of radiotherapy during treatment. This is to target the cancer better and to have less treatment go to the surrounding organs.
This trial is for people with cancer that developed from squamous cells (squamous cell carcinoma) that has come back or spread to other parts of the body.
A study to develop a way of predicting long term side effects of radiotherapy (Hamlet-RT)
This trial is for people who have had treatment for head and neck cancer and have a high risk of the cancer coming back or getting worse.
This trial is for people with head and neck cancer who are going to have treatment for the first time.
